To the Editor: The recent editorial by Collignon and colleagues challenged Australian physicians and health care leaders to confront the rising burden of methicillin-resistant Staphylococcus aureus (MRSA).1 Compared with Australia, the United States has a bigger problem with MRSA; more than 60% of all hospital-acquired S. aureus infections are now caused by MRSA.2
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Collignon PJ, Grayson ML, Johnson PDR. Methicillin-resistant Staphylococcus aureus in hospitals: time for a culture change [editorial]. Med J Aust 2007; 187: 4-5. <MJA full text>
- 2. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32: 470-485.
- 3. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006; 166: 1945-1951.
- 4. Weber SG, Huang SS, Oriola S, et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol 2007; 28: 249-260.
- 5. Kaye KS, Engemann JJ, Fulmer EM, et al. Favorable impact of an infection control network on nosocomial infection rates in community hospitals. Infect Control Hosp Epidemiol 2006; 27: 228-232.
Online responses are no longer available. Please refer to our instructions for authors page for more information.
Deverick Anderson sits on the Regional Advisory Panel for Pfizer and Schering–Plough.